CYPH
CYPH
NASDAQ · Biotechnology

Cypherpunk Technologies Inc

$0.64
0.00 (-0.62%)
As of Aug 15, 2:25 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +5,912.4% upside
Low Target $25.17
Average Target $38.72
High Target $55.57
Current Price $0.64
Current
$0.64
Target
$38.72
$25.17 $38.72 avg $55.57
Scenario Analysis
Bear Case
$25.17
3,808.4%
Low target
Base Case
$38.72
+5,912.4%
Avg target
Bull Case
$55.57
+8,528.9%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$3.70
-82.6% from high
52-Week Low
$0.23
+177.6% from low
Target vs 52W High
$38.72
+946.5% vs high
Next Earnings Report
Aug 17, 2026
1d
tomorrow
EPS Est: $-0.03
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%